APA (7th ed.) Citation

JJ, K., MG, M., IS, B., DY, O., O, Z., V, B., . . . JW, V. (2025). A phase III randomized study of first-line NUC-1031/cisplatin vs. gemcitabine/cisplatin in advanced biliary tract cancer. Journal of hepatology, 83(2), 358. https://doi.org/10.1016/j.jhep.2025.01.040

Chicago Style (17th ed.) Citation

JJ, Knox, et al. "A Phase III Randomized Study of First-line NUC-1031/cisplatin Vs. Gemcitabine/cisplatin in Advanced Biliary Tract Cancer." Journal of Hepatology 83, no. 2 (2025): 358. https://doi.org/10.1016/j.jhep.2025.01.040.

MLA (9th ed.) Citation

JJ, Knox, et al. "A Phase III Randomized Study of First-line NUC-1031/cisplatin Vs. Gemcitabine/cisplatin in Advanced Biliary Tract Cancer." Journal of Hepatology, vol. 83, no. 2, 2025, p. 358, https://doi.org/10.1016/j.jhep.2025.01.040.